Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ki67 Blocking Peptide | Login | Ki67 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Ki67 Blocking Peptide | Login | Ki67 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
GPCR LGR6 Blocking Peptide | Login | GPCR LGR6 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Alpha Fetoprotein Blocking Peptide | Login | Alpha Fetoprotein Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
MAP3K8 Blocking Peptide | Login | MAP3K8 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
MAPK2 Blocking Peptide | Login | MAPK2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CD10 Positive Control | Login | CD10 Positive Control | ||||||||||||||||
|
||||||||||||||||||
nmt55 / p54nrb Positive Control | Login | nmt55 / p54nrb Positive Control | ||||||||||||||||
|
||||||||||||||||||
KAT13C / NCOA2 Positive Control | Login | KAT13C / NCOA2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
GTPase HRAS Positive Control | Login | GTPase HRAS Positive Control | ||||||||||||||||
|
||||||||||||||||||
p75 NGF Receptor Positive Control | Login | p75 NGF Receptor Positive Control | ||||||||||||||||
|
||||||||||||||||||
PAX2 Positive Control | Login | PAX2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
PAX8 Positive Control | Login | PAX8 Positive Control | ||||||||||||||||
|
||||||||||||||||||
PD-L1 Positive Control | Login | PD-L1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
PD-L2 Positive Control | Login | PD-L2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Progesterone Receptor Positive Control | Login | Progesterone Receptor Positive Control | ||||||||||||||||
|
||||||||||||||||||
cGKI Positive Control | Login | cGKI Positive Control | ||||||||||||||||
|
||||||||||||||||||
RUNX1 / AML1 Positive Control | Login | RUNX1 / AML1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
S100 beta Positive Control | Login | S100 beta Positive Control | ||||||||||||||||
|
||||||||||||||||||
Septin 2 Positive Control | Login | Septin 2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Septin 3 Positive Control | Login | Septin 3 Positive Control | ||||||||||||||||
|
||||||||||||||||||
SEPT6 Positive Control | Login | SEPT6 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Smad4 Antibody Positve Control | Login | Smad4 Antibody Positve Control | ||||||||||||||||
|
||||||||||||||||||
Sequestosome-1 Positive Control | Login | Sequestosome-1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Galectin 3 Blocking Peptide | Login | Galectin 3 Blocking Peptide | ||||||||||||||||
|